vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $49.0M, roughly 111.7× Quipt Home Medical Corp.). Fresenius Medical Care AG runs the higher net margin — 7.9% vs -2.1%, a 10.1% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
FMS vs QIPT — Head-to-Head
Income Statement — Q4 2025 vs Q1 2026
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $49.0M |
| Net Profit | $434.2M | $-1.1M |
| Gross Margin | 27.4% | 53.5% |
| Operating Margin | 11.7% | 2.1% |
| Net Margin | 7.9% | -2.1% |
| Revenue YoY | -0.3% | 32.3% |
| Net Profit YoY | 240.4% | 2.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $49.0M | ||
| Q3 25 | — | $39.8M | ||
| Q2 25 | — | $35.1M | ||
| Q1 25 | — | $33.3M | ||
| Q4 24 | $5.5B | $37.1M |
| Q4 25 | $434.2M | $-1.1M | ||
| Q3 25 | — | $-3.5M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | $127.6M | $-1.1M |
| Q4 25 | 27.4% | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | 25.0% | 52.1% |
| Q4 25 | 11.7% | 2.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | — | -5.2% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | 5.1% | 1.2% |
| Q4 25 | 7.9% | -2.1% | ||
| Q3 25 | — | -8.9% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -9.1% | ||
| Q4 24 | 2.3% | -2.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $15.4B | $113.0M |
| Total Assets | $33.5B | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $10.5M | ||
| Q3 25 | — | $12.9M | ||
| Q2 25 | — | $11.3M | ||
| Q1 25 | — | $17.1M | ||
| Q4 24 | $1.3B | $15.5M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M |
| Q4 25 | $15.4B | $113.0M | ||
| Q3 25 | — | $112.1M | ||
| Q2 25 | — | $102.5M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | $17.0B | $106.3M |
| Q4 25 | $33.5B | $280.7M | ||
| Q3 25 | — | $283.3M | ||
| Q2 25 | — | $236.1M | ||
| Q1 25 | — | $244.6M | ||
| Q4 24 | $36.3B | $242.8M |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $8.9M |
| Free Cash FlowOCF − Capex | — | $6.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | 6.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $8.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $2.6B | $9.3M |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% |
| Q4 25 | 6.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
